Skip to content

Epicardial Mapping Studies in Patients undergoing Cardiac Surgery Roepnaam Quasar

Epicardial Mapping Studies in Patients undergoing Cardiac Surgery Roepnaam Quasar - Epicardial Mapping Studies in Patients undergoing Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39666
Enrollment
650
Registered
2010-05-04
Start date
2010-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Epicardial mapping during CABG

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients > 18 years scheduled for standard cardiac surgery.

Exclusion criteria

Exclusion criteria: paced atrial rhythms usage of anti-arrhythmic drugs hemodynamic instability presence of assist devices usage of inotropic agents emergency cardiac surgery redo-cardiac surgery

Design outcomes

Primary

MeasureTime frame
The main endpoint of the study is reached when atrial fibrillation develops. There is a follow-up period of 5 years after cardiac surgery. Each year, the participant will be called by the investigator in order to check whether atrial fibrillation has occurred.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)